Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Hepatology International
Published in: Hepatology International 5/2020

01-09-2020 | SARS-CoV-2 | Letter to the Editor

Proposed mechanism for increased COVID-19 mortality in patients with decompensated cirrhosis

Authors: Josephine A. Grace, Stephen Casey, Louise M. Burrell, Peter W. Angus

Published in: Hepatology International | Issue 5/2020

Login to get access

Excerpt

We read with interest the article by Qi et al. on the clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis [1]. We wish to draw attention to a possible contribution of increased hepatic expression of angiotensin converting enzyme 2 (ACE2) and ACE to explain the poor outcomes in these patients. …
Literature
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
Metadata
Title
Proposed mechanism for increased COVID-19 mortality in patients with decompensated cirrhosis
Authors
Josephine A. Grace
Stephen Casey
Louise M. Burrell
Peter W. Angus
Publication date
01-09-2020
Publisher
Springer India
Published in
Hepatology International / Issue 5/2020
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-020-10084-4

Other articles of this Issue 5/2020

Hepatology International 5/2020 Go to the issue

Original Article

Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis

Original Article

Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)

Review Article

Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis

Review Article

Novel systemic therapy for hepatocellular carcinoma

Review Article

Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis

Original Article

Silencing of functional p53 attenuates NAFLD by promoting HMGB1-related autophagy induction
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits